(Q47816457)

English

Low-density lipoprotein receptor genotype-dependent response to cholesterol lowering by combined pravastatin and cholestyramine in familial hypercholesterolemia

scientific article published in July 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9671018

Low-density lipoprotein receptor genotype-dependent response to cholesterol lowering by combined pravastatin and cholestyramine in familial hypercholesterolemia (English)

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9671018

hypercholesterolemia

0 references

author name string

Kajinami K

1

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9671018

Yagi K

2

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9671018

Higashikata T

3

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9671018

Inazu A

4

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9671018

Koizumi J

5

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9671018

Mabuchi H

6

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9671018

language of work or name

0 references

publication date

1 July 1998

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9671018

American Journal of Cardiology

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9671018

82

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9671018

1

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9671018

113-117

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9671018

Molecular genetics of the LDL receptor gene in familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900230-6

7 January 2021

Development of coronary heart disease in familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900230-6

7 January 2021

Causes of death in patients with familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900230-6

7 January 2021

Is responsiveness to lovastatin in familial hypercholesterolaemia heterozygotes influenced by the specific mutation in the low-density lipoprotein receptor gene?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900230-6

7 January 2021

Influence of specific mutations at the LDL-receptor gene locus on the response to simvastatin therapy in Afrikaner patients with heterozygous familial hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900230-6

7 January 2021

Reduction of serum cholesterol in heterozygous patients with familial hypercholesterolemia. Additive effects of compactin and cholestyramine

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900230-6

7 January 2021

New variant of low density lipoprotein receptor gene. FH-Tonami

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900230-6

7 January 2021

Serum apolipoproteins in heterozygous familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900230-6

7 January 2021

Reduction of lipoprotein(a) by LDL-apheresis using a dextran sulfate cellulose column in patients with familial hypercholesterolemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900230-6

7 January 2021

Clinical characteristics of double heterozygotes with familial hypercholesterolemia and cholesteryl ester transfer protein deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900230-6

7 January 2021

Identification of a point mutation in growth factor repeat C of the low density lipoprotein-receptor gene in a patient with homozygous familial hypercholesterolemia that affects ligand binding and intracellular movement of receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900230-6

7 January 2021

Effects of ML-236B (Compactin) on Sterol Synthesis and Low Density Lipoprotein Receptor Activities in Fibroblasts of Patients with Homozygous Familial Hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900230-6

7 January 2021

Effects of CS-514 on serum lipoprotein lipid and apolipoprotein levels in patients with familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900230-6

7 January 2021

Treatment of familial hypercholesterolaemia: a controlled trial of the effects of pravastatin or cholestyramine therapy on lipoprotein and apolipoprotein levels

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900230-6

7 January 2021

Pravastatin in heterozygous familial hypercholesterolemia: low-density lipoprotein (LDL) cholesterol-lowering effect and LDL receptor activity on skin fibroblastS

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900230-6

7 January 2021

Identifiers

10.1016/S0002-9149(98)00230-6

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9671018

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9671018

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47816457&oldid=2172077539"